NDATRANSDERMALGEL
Approved
Jan 2009
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
3
Data completeness
6/8 — Strong
GELNIQUE (oxybutynin chloride) by AbbVie is clinical pharmacology oxybutynin chloride exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. Approved for overactive bladder. First approved in 2009.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GELNIQUE is a transdermal gel formulation of oxybutynin chloride, an anticholinergic agent approved in 2009 for overactive bladder. It works by exerting direct antispasmodic effects on bladder smooth muscle and inhibiting muscarinic acetylcholine activity, increasing bladder capacity and reducing urgency and incontinence episodes. The product is indicated for overactive bladder and has off-label use in managing hot flashes associated with breast cancer, prostate cancer, and menopause.
$0.816MPart D
PeakStable
4.9 years to LOEProduct is at peak lifecycle with modest Medicare spending; commercial team likely focused on maintaining market position rather than growth expansion.
Mechanism of Action
CLINICAL PHARMACOLOGY Oxybutynin chloride exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. Oxybutynin chloride exhibits only one fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to…
Worked on GELNIQUE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.